Sysmex Europe
Menu

Difference of RET and RBC haemoglobin content (Delta-He)

What is Delta-He parameter?

The Delta-He parameter reflects the difference between the haemoglobin equivalent of reticulocytes (RET-He) and the haemoglobin content of mature red blood cells (RBC-He). Under physiological conditions, the value of the diagnostic parameter is positive because the haemoglobin content in reticulocytes is higher than in mature red blood cells. Negative values result from a lower degree of haemoglobinisation in newly formed reticulocytes compared to mature erythrocytes. It is available from a routine laboratory analysis of an EDTA blood sample.

 

How is Delta-He calculated?

Delta-He is calculated by subtracting RBC-He from RET-He. RET-He is a diagnostic parameter obtained from Sysmex’s haematology analysers equipped with a RET channel. In the RET channel, all reticulocytes are stained with a fluorescent dye and counted. The population in the area of high fluorescence intensity is separated as reticulocytes and the RET-He parameter is derived from the mean forward scatter light of reticulocyte population. Similarly, RBC-He is a diagnostic parameter and it is derived from the mean forward scattered light of the RBC population in the RET scattergram.

Reference ranges (adults)

Delta-He: 1.2 - 3.6 pg (0.07 - 0.22 fmol) [1]

Statement

Our results emphasize the diagnostic potential of Delta-He regarding the rapid detection of a bacterial infection in a patient’s blood, which is comparable to the diagnostic value of CRP or PCT. (Zimmermann M et al. 2021)

Benefits

These clinical benefits were reported in the scientific literature for the Delta-He parameter:

  • Serves as a marker of impaired haemoglobinisation of newly formed reticulocytes occurring during inflammatory processes, which helps to differentiate between different disease-specific types of anaemia [2].
  • It is part of the ‘Haema plot’ tool, developed for differential diagnosis and disease monitoring in various types of disease-specific anaemia and for identifying non-adherent patients or inadequate therapy [2].
  • Delta-He was found to be associated with inflammation, response to erythropoietin stimulating agents and mortality risk in peritoneal dialysis patients [3].
  • The Delta-He parameter supports the detection of bacterial infection in the patient’s blood [4,5].
  • Delta-He has demonstrated promising supportive capabilities to diagnose iron deficiency anaemia and functional iron deficiency in critically ill patients in the ICU [6].


Copyright © Sysmex Europe SE. All rights reserved.